| Liothyronine | Approved Investigational Vet Approved | ADD2 | 119 |
upregulated | Triiodothyronine results in increased expression of ADD2 mRNA | 2p13.3 | |
| Liothyronine | Approved Investigational Vet Approved | ADH1B | 125 |
downregulated | Triiodothyronine results in decreased expression of ADH1B mRNA | 4q23 | |
| Liothyronine | Approved Investigational Vet Approved | ADRB2 | 154 |
upregulated | Triiodothyronine results in increased expression of ADRB2 mRNA | 5q32 | |
| Liothyronine | Approved Investigational Vet Approved | AKAP12 | 9590 |
upregulated | Triiodothyronine results in increased expression of AKAP12 mRNA | 6q25.1 | |
| Liothyronine | Approved Investigational Vet Approved | AKIRIN2 | 55122 |
upregulated | Triiodothyronine results in increased expression of AKIRIN2 mRNA | 6q15 | |
| Liothyronine | Approved Investigational Vet Approved | AKR1C1 | 1645 |
upregulated | Triiodothyronine results in increased expression of AKR1C1 mRNA | 10p15.1 | |
| Liothyronine | Approved Investigational Vet Approved | AKR1C2 | 1646 |
upregulated | Triiodothyronine results in increased expression of AKR1C2 mRNA | 10p15.1 | |
| Liothyronine | Approved Investigational Vet Approved | AKR1C3 | 8644 |
upregulated | Triiodothyronine results in increased expression of AKR1C3 mRNA | 10p15.1 | |
| Liothyronine | Approved Investigational Vet Approved | APOL1 | 8542 |
downregulated | Triiodothyronine results in decreased expression of APOL1 mRNA | 22q12.3 | |
| Liothyronine | Approved Investigational Vet Approved | APP | 351 |
downregulated | Triiodothyronine results in decreased expression of APP mRNA | 21q21.3 | |
| Liothyronine | Approved Investigational Vet Approved | ARHGEF25 | 115557 |
downregulated | Triiodothyronine results in decreased expression of ARHGEF25 mRNA | 12q13.3 | |
| Liothyronine | Approved Investigational Vet Approved | ASPM | 259266 |
downregulated | Triiodothyronine results in decreased expression of ASPM mRNA | 1q31.3 | |
| Liothyronine | Approved Investigational Vet Approved | BMP6 | 654 |
downregulated | Triiodothyronine results in decreased expression of BMP6 mRNA | 6p24.3 | |
| Liothyronine | Approved Investigational Vet Approved | BTN2A1 | 11120 |
downregulated | Triiodothyronine results in decreased expression of BTN2A1 mRNA | 6p22.2 | |
| Liothyronine | Approved Investigational Vet Approved | CCDC71 | 64925 |
downregulated | Triiodothyronine results in decreased expression of CCDC71 mRNA | 3p21.31 | |
| Liothyronine | Approved Investigational Vet Approved | CCL5 | 6352 |
upregulated | Triiodothyronine results in increased expression of CCL5 mRNA | 17q12 | |
| Liothyronine | Approved Investigational Vet Approved | CDKN1A | 1026 |
upregulated | Triiodothyronine results in increased expression of CDKN1A mRNA | 6p21.2 | |
| Liothyronine | Approved Investigational Vet Approved | COL6A3 | 1293 |
upregulated | Triiodothyronine results in increased expression of COL6A3 mRNA | 2q37.3 | |
| Liothyronine | Approved Investigational Vet Approved | CPT1A | 1374 |
upregulated | Triiodothyronine results in increased expression of CPT1A mRNA | 11q13.3 | |
| Liothyronine | Approved Investigational Vet Approved | CRACR2B | 283229 |
downregulated | Triiodothyronine results in decreased expression of CRACR2B mRNA | 11p15.5 | |
| Liothyronine | Approved Investigational Vet Approved | CYP24A1 | 1591 |
upregulated | Triiodothyronine results in increased expression of CYP24A1 mRNA | 20q13.2 | |
| Liothyronine | Approved Investigational Vet Approved | CYP3A4 | 1576 |
upregulated | Triiodothyronine results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Liothyronine | Approved Investigational Vet Approved | DIO3 | 1735 |
upregulated | Triiodothyronine results in increased expression of DIO3 mRNA | 14q32.31 | |
| Liothyronine | Approved Investigational Vet Approved | DUSP2 | 1844 |
downregulated | Triiodothyronine results in decreased expression of DUSP2 mRNA | 2q11.2 | |
| Liothyronine | Approved Investigational Vet Approved | DYNC1LI2 | 1783 |
upregulated | Triiodothyronine results in increased expression of DYNC1LI2 mRNA | 16q22.1 | |